Skip to main content

NWBO Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Northwest Biotherapeutics Inc News

Northwest Bio Receives SEC Subpoena and Other Awful Nuggets From New 10-K

Imagine a derailed freight train carrying dumpsters on fire. That's an accurate description of the Northwest Bio 10-K filed Monday night.

Northwest Bio Executive Pleads Ignorance about Clinical Trial Halt, Stock Collapse

Northwest's inability to resolve the problems that froze the DCVax-L clinical trial -- and management's refusal to offer a public explanation for why it happened -- triggered the company's collapse.

Northwest Biotherapeutics agrees to pay bondholders $11 million, needs cash

Northwest Biotherapeutics, a regular visitor to the capital markets, has negotiated a note payment schedule with Whitebox Advisors.

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

Biotech school: How to spot hidden danger signs in clinical trial data

Using Northwest Bio as an example, I'm going to teach you how to read clinical trial data to find red flags and bad stuff biotechs don't want you to see.

Breaking News

Elon Musk Says Only Two Things Could Make Him Leave Tesla

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

Caesars Inches Closer to Huge Las Vegas Strip Move

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023